|
Market Cap (23-May) $4,114,900 (1,059th) |
Close (30-Jun) $0.010 |
Volume (30-Jun) 1,641,703 |
Shortsold (24-Jan) 39,007 (0.00%) (630th) |
|
52w High $0.008 |
52w Low $0.002 |
P/E - |
EPS 0 |
PAB released this announcement to the ASX on 4 July 2022, 9:08. The announcement is marked as price sensitive, and is 3 page(s) in length and 220.68kb in size.
You can view all announcements from PAB and see how they appear on a price chart on the announcements page.
At the date of this announcement, PAB was 0.109% short sold according to ASIC data. It was ranked the 491st most shorted stock on the ASX. It remains ranked 630th as of the latest reported data (24 January 2025).
| Other Recent Announcements from PAB | |
|---|---|
| PAT-DX1 GLP toxicology reports received | 24 May 2023, 9:12 |
| Notification regarding unquoted securities - PAB | 11 May 2023, 14:04 |
| Appendix 4C - Quarterly - 31 March 2023 | 24 April 2023, 10:10 |
| PAT-DX1 Engineering Run Successfully Completed | 4 July 2022, 9:08 |
| New Mechanism By Which PAT-DX1 May Reduce Cancer Metastasis | 14 June 2022, 8:53 |
| CBCF funding to support deoxymab brain cancer development | 3 June 2022, 14:07 |
| Patrys CEO to present at Bioshares Biotech Summit | 11 May 2022, 9:50 |
You must be logged in to post a reply.
Patrys 